Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate.
van Vliet
H A A M
HA
Winkel
T A
TA
Noort
I
I
Rosing
J
J
Rosendaal
F R
FR
D020016:Activated Protein C Resistance / Q000175:diagnosis; D000293:Adolescent; D000328:Adult; D000736:Androstenes / Q000009:adverse effects; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D017373:Cyproterone Acetate / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D019851:Thrombophilia / Q000139:chemically induced* / Q000175:diagnosis
D000736:Androstenes; D003277:Contraceptives, Oral, Combined; D017373:Cyproterone Acetate; C035144:drospirenone